Literature DB >> 10872654

Low-grade intraosseous osteosarcoma in northern Japan: advantage of AgNOR and MIB-1 staining in differential diagnosis.

K Okada1, J Nishida, T Morita, H Kakizaki, A Ishikawa, T Hotta.   

Abstract

Low-grade intraosseous osteosarcoma is an uncommon form of bone cancer. It is occasionally difficult to recognize as a malignant tumor and is commonly misdiagnosed as a benign fibrous lesion. We retrospectively studied the records of 8 patients with low-grade intraosseous osteosarcoma in the files of the Tohoku Musculoskeletal Tumor Society in Japan. All tumors arose in the lower limb. The most common symptom was pain, with a duration exceeding 2 years in 4 patients. Radiologic findings, including those at magnetic resonance imaging (MRI), suggested malignancy in 5 lesions, whereas 3 were diagnosed as benign. Two patients initially presented with pathological fracture. The initial pathological diagnosis was malignant in 5 patients and benign in 3. All eight tumors were grade 1 in Broders' classification. The tumor showed a permeative pattern in all eight cases, but this pattern could not be confirmed in the multiple tiny fragments obtained as biopsy specimens in 3 cases. The number of silver-staining nucleolar organizer regions (AgNOR) per nucleus and MIB-1-positive rate were significantly higher in low-grade intraosseous osteosarcoma than in fibrous dysplasia, offering an advantage in differential diagnosis. Three patients (38%) developed high-grade sarcoma at the site of local recurrence after multiple intralesional excisions, and one of them died of the disease. The other 5 patients had a good clinical course after surgery with a wide margin. These findings indicate that preoperative diagnosis with radiologic investigation, including magnetic resonance (MR) imaging and histologic examination of biopsy specimens is essential in preparation for surgery with a wide margin, assuring a good clinical course, and the results of AgNOR and immunohistochemical MIB-1 staining might be helpful in differentiating low-grade intraosseous osteosarcoma from fibrous dysplasia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10872654     DOI: 10.1053/hupa.2000.8231

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  4 in total

1.  Multifocal low-grade central osteosarcoma: a rare case.

Authors:  Richard Boyle; Bruno Giuffre; S Fiona Bonar
Journal:  Skeletal Radiol       Date:  2016-04-05       Impact factor: 2.199

2.  Diagnosis and treatment of low-grade osteosarcoma: experience with nine cases.

Authors:  Katsuhiro Hayashi; Hiroyuki Tsuchiya; Norio Yamamoto; Toshiharu Shirai; Hideji Nishida; Akihiko Takeuchi; Hiroaki Kimura; Shinji Miwa; Hiroyuki Inatani; Hideki Okamoto; Satoshi Yamada; Hiroko Ikeda; Seiko Sawada-Kitamura; Takayuki Nojima; Akishi Ooi; Takanobu Otsuka
Journal:  Int J Clin Oncol       Date:  2013-07-24       Impact factor: 3.402

3.  Low-grade central osteosarcoma in proximal humerus: a rare entity.

Authors:  Fan Tang; Li Min; Yong Zhou; Yi Luo; Chongqi Tu
Journal:  Onco Targets Ther       Date:  2017-10-24       Impact factor: 4.147

4.  Immunohistochemical Estimates of Angiogenesis, Proliferative Activity, p53 Expression, and Multiple Drug Resistance Have No Prognostic Impact in Osteosarcoma: A Comparative Clinicopathological Investigation.

Authors:  Flemming Brandt Sorensen; Kenneth Jensen; Michael Vaeth; Henrik Hager; Anette Mariane Daa Funder; Akmal Safwat; Johnny Keller; Mariann Christensen
Journal:  Sarcoma       Date:  2009-02-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.